商业 · 1999/9/231 分钟阅读
Beecham Laboratories et al.; Withdrawal of Approval of 44 Abbreviated New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of 44 abbreviated new drug applications (ANDA's). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.